ITT industrial machinery and SPX FLOW frame a $1M CEO stock purchase against $23M in prior sales and a premium 25x forward P/E.

⚙️ ITT Inc. (ITT): CEO Buys $1M After Selling $23M—Is the Dip Really a Buy?

ITT CEO Luca Savi just bought approximately $1 million of stock after previously selling more than $23 million. Meanwhile, the $4.8 billion SPX FLOW acquisition is transforming ITT, organic revenue grew nearly 13%, and guidance is rising—but at roughly 25x forward earnings, investors are already paying for plenty of success. We dig into the insider signal, fundamentals, valuation, institutional ownership and risks.

 

Read entire article

Illustration of a biotechnology researcher and investor reviewing Kura Oncology charts beside a rising oncology treatment pipeline, highlighting KURA stock analysis, KOMZIFTI commercialization and biotech growth.

🧬 Kura Oncology (KURA) Stock Analysis: From Clinical Promise to Commercial Reality

Kura Oncology is evolving from a clinical-stage biotech into a commercial oncology company. With KOMZIFTI gaining traction, over $500 million in cash, strong institutional ownership and multiple Phase 3 catalysts ahead, is KURA becoming one of biotech's most compelling long-term opportunities?

Read entire article

A modern software development control center displaying AI-assisted coding and source code flowing through an integrated DevSecOps pipeline, with a CEO silhouette purchasing shares, symbolizing GitLab's insider buying and long-term investment potential.

💻 GitLab (GTLB): Triple CEO Buying, AI Tailwinds, a $400 Million Buyback, and Why This Software Leader May Be Too Cheap to Ignore

GitLab isn't simply riding the AI boom—it helps build it. With repeated insider buying by CEO William Staples, a $400 million buyback authorization, strong free cash flow, and an integrated DevSecOps platform, GitLab may represent one of enterprise software's more overlooked long-term opportunities.

Read entire article

Editorial illustration of a glowing PayPal digital wallet at the center of a global payment network, surrounded by flowing transaction lines and digital commerce, representing a deeply discounted fintech giant poised for a potential turnaround.

💳 PayPal (PYPL): An 8× P/E, a CFO Insider Buy, and Why This FinTech Giant May Be Too Cheap to Ignore

PayPal has lost more than 85% of its value since 2021, yet it continues to grow revenue, generate billions in free cash flow, and aggressively repurchase shares. Has Wall Street become too pessimistic, or is PYPL a classic value trap? We examine the bull case, the risks, and what could reignite growth.

Read entire article

Elegant illustration of a luxurious RH-inspired modern estate featuring designer furniture, upward financial charts, institutional investor icons, a coiled spring symbolizing high short interest, representing RH's luxury turnaround and growth ambitions.

🏰 RH (NYSE: RH): Insider Buying, 34% Short Interest, and a Luxury Turnaround Worth Watching

RH isn't just selling luxury furniture anymore—it's trying to redefine luxury living. With a major insider purchase, elevated short interest, ambitious global expansion, and Wall Street split on the outlook, RH may be one of today's most intriguing turnaround stories.

Read entire article

Illustration showing everyday investors boarding a futuristic launch pad called Powerlaw that provides access to rockets labeled SpaceX, OpenAI, Kalshi, Stripe, Anthropic, Waymo, and Canva.

🛰️ The Venture Secondary Discount: Inside Powerlaw's Pre-IPO Liquidity Arbitrage

Powerlaw isn't simply another investment company—it's a gateway into some of the world's most valuable private technology businesses. With insider buying near NAV and holdings including SpaceX, OpenAI, Kalshi, Stripe and Anthropic, investors must answer one key question: are they buying today's NAV, or tomorrow's?

Read entire article

A futuristic financial city where a giant golden hooded robin stands atop a glowing fintech platform. Streams of digital assets flow toward the platform from younger investors carrying smartphones

🚀 Robinhood (HOOD): The $35M Insider Bet, the Great Wealth Transfer, and the Price of Fintech Dominance

Robinhood has evolved far beyond a commission-free trading app. With $307 billion in platform assets, 4.3 million Gold subscribers, and a $35 million insider purchase from fintech legend Meyer Malka, the company is increasingly positioning itself at the center of the next generation's financial lives.

Read entire article

Illustration of a fast-growing drive-thru coffee chain featuring sleek modern coffee bars, customers lined up for espresso, glowing stock charts, and coffee beans transforming into bullish financial arrows symbolizing Black Rock Coffee Bar’s fast growth.

☕ Black Rock Coffee Bar (BRCB): The Hypergrowth Coffee Chain Wall Street May Have Oversold

Black Rock Coffee Bar (NASDAQ: BRCB) may be one of the market’s more fascinating small-cap growth stories hiding beneath a brutal selloff. With insider buying accelerating, revenue climbing nearly 24%, and profitability improving, investors are beginning to wonder whether Wall Street overshot the downside.

Read entire article

A glowing digital shield protecting a futuristic data network, symbolizing cybersecurity and Palo Alto Networks’ role in defending against cyber threats.

PANW Stock Analysis 2026: Why CEO Nikesh Arora Just Bet $10M on Palo Alto Networks 🛡️

PANW is the “Microsoft of cybersecurity”—dominant, profitable, and growing fast. But with premium valuation and heavy institutional ownership, is now the right time to buy?

Read entire article

Playful digital illustration of Ryan Specialty’s executive chairman standing confidently on a skyscraper-sized insurance policy with a cash briefcase, as Wall Street skyline and insurance icons highlight insider buying and institutional support.

Executive Chairman Adds To His Already Huge Stake in Ryan Specialty Holdings. Should You Follow His Lead?

Executive Chairman Patrick Ryan just added $14M to his already massive stake in Ryan Specialty Holdings. With strong revenue growth and heavy institutional backing, is this insurance play worth your portfolio — or is it still too pricey?

 

Read entire article